Results 131 to 140 of about 10,082 (205)

Curative outcomes with metal-containing TCM in diabetic foot ulcers unresponsive to standard therapy: a case series. [PDF]

Front Endocrinol (Lausanne)
Zhang Y, Yu C, Qu X, Li Q, Dai G, Long W, Kong H, Qu H, Xu X, Zhang Y, Zhao Y.   +10 more
europepmc   +1 more source

Insulin edema in slowly progressive type 1 diabetes: improvement following adjustment of insulin therapy. [PDF]

Diabetol Int
Okamura E, Harada N, Okuno K, Yamamoto K, Murakami T, Ueda Y, Yabe D.   +6 more
europepmc   +1 more source

Effects of Different Exogenous Insulin Analog Treatments on the Evaluation of Pancreatic Islet Function in Diabetes. [PDF]

J Diabetes Res
Ma YF, Neng QL, Ou Y, Zhou YK.
europepmc   +1 more source

Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 study. [PDF]

J Diabetes Investig
Gao L, Cheng Z, Ma G, Cai X, Wang X, Lu Y, Li Z, Li W, Zhao S, Li X, Song C, Gao Y, Geng J, Cao H, Sun J, Ji L.   +15 more
europepmc   +1 more source

Type 2 diabetes mellitus complicated by acquired reactive perforating collagenosis: A case report and literature review. [PDF]

Medicine (Baltimore)
Li L, Wu H, Zhao L.
europepmc   +1 more source

Lipid level stabilization following combination therapy with IdaGlar and Semaglutide in type 2 diabetes: a retrospective study. [PDF]

Am J Transl Res
Li F, Li J, Liu J.
europepmc   +1 more source

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients. [PDF]

Clin Pharmacol Ther
Iacono A, Ho MKH, Yang J, Campbell T, Wynne W, Shearer D, Andersen L, Majer E, Ledlie S, Tadrous M, Gomes T.   +10 more
europepmc   +1 more source

Impact of structure and formulation changes on the function of insulin products. [PDF]

Front Endocrinol (Lausanne)
Yang Y, Shahinozzaman M, Shin H, Bupp S, Sourbier C.   +4 more
europepmc   +1 more source

Comparison of pharmacodynamics and pharmacokinetics of ultra-rapid-acting insulin aspart and rapid-acting insulin aspart around continuous moderate intensity exercise in adults with type 1 diabetes: A randomised controlled trial. [PDF]

Diabetes Obes Metab
Pitt JP, Müller A, Nicholas C, McCarthy OM, Moser O, Bain SC, Sourij H, Bracken RM.   +7 more
europepmc   +1 more source

Monomeric Insulin Analog and Stabilizing Excipient Enabled Ultrafast Insulin Formulation. [PDF]

Adv Mater
Zhang Y, Lin T, Tran NLB, Jung J, Blakely A, Dao Y, Austin MJ, Lal RA, Hill CP, Chou DH.   +9 more
europepmc   +1 more source